| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |